Bayesian Capital Management, LP Relay Therapeutics, Inc. Transaction History
Bayesian Capital Management, LP
- $854 Million
- Q2 2024
A detailed history of Bayesian Capital Management, LP transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 43,900 shares of RLAY stock, worth $284,911. This represents 0.03% of its overall portfolio holdings.
Number of Shares
43,900
Previous 38,600
13.73%
Holding current value
$284,911
Previous $320,000
10.63%
% of portfolio
0.03%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding RLAY
# of Institutions
182Shares Held
126MCall Options Held
1.7KPut Options Held
18K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$181 Million1.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$76 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$68.4 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.45MShares$54.8 Million4.77% of portfolio
-
Bellevue Group Ag Kuesnacht, V86.38MShares$41.4 Million0.7% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $780M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...